BACKGROUND: Conventional PTCA for the treatment of @entity75 is associated with a high rate of recurrence (30-50%). Primary stenting decreases the @entity256 rate at long-term follow-up. METHODS: One-hundred consecutive @entity1 with @entity256 received a Bard XT stent. Follow-up angiography was performed after 6 months. Angiograms were compared by means of computed quantitative analysis. RESULTS: The mean pretreatment reference diameter was 2.88 +/- 0.51 mm. The mean @entity5562 ( @entity5562 ) increased from 1.09 +/- 0.57 mm to 2.70 +/- 0.44 mm. The percent diameter stenosis decreased from 66 +/- 13% to 15 +/- 10%. The procedural success rate was 99%. At 6 month follow-up repeat angiography was performed in 86 @entity1 . The mean @entity5562 was 1.74 +/- 0.67 mm with a mean diameter stenosis of 41 +/- 20%. @entity41 were reported in 29% of @entity1 . In-stent @entity256 (defined as diameter stenosis of more than 50%) occurred in 18% of the @entity1 . CONCLUSION: Placement of the Bard XT stent in @entity75 is feasible, has an excellent short term outcome and yields a favorable result at 6 month follow-up angiography.

Stenting for XXXX with the BARD XT stent.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity41 :: ('MESH:D018365', 'Disease') :: ['Residual anginal complaints'] @entity75 :: ('MESH:D001927', 'Disease') :: ['restenotic lesions'] @entity256 :: ('MESH:D023903', 'Disease') :: ['restenosis'] @entity5562 :: ('MESH:D015875', 'Disease') :: ['minimal luminal diameter', 'MLD']
@entity75 :: (MESH:D001927,Disease) :: ['restenotic lesions']
